Lv2
167 积分 2021-06-09 加入
Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides
1天前
已完结
ANCA-associated vasculitides—advances in pathogenesis and treatment
1天前
已完结
Complement in ANCA-associated vasculitis: mechanisms and implications for management
1天前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
20天前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
20天前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
20天前
已完结
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
20天前
已完结
NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome
20天前
已完结
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial
20天前
已完结
Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy
20天前
已完结
皖公网安备34019202002308
